# Investview, Inc.: financial statements, quarterly

INVU · OTC · CIK 862651 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/invu.md) · [Financials](/companies/invu/financials.md) · [Filings](/companies/invu/filings.md) · [Insiders](/companies/invu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/invu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [19.2](/filings/0001493152-24-045065.md) | [17.9 d](/filings/0001641172-25-001193.md) | [15.7](/filings/0001641172-25-010230.md) | [13.1](/filings/0001493152-25-011912.md) | [11.7](/filings/0001493152-25-022223.md) | [11.9 d](/filings/0001493152-26-014042.md) | [10.0](/filings/0001493152-26-023510.md) | [9.2](/filings/0001493152-26-038191.md) | [9.1](/filings/0001493152-25-022223.md) | [7.1 d](/filings/0001493152-26-014042.md) | [3.9](/filings/0001493152-26-023510.md) | [2.5](/filings/0001493152-26-038191.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [0.0 d](/filings/0001493152-23-040281.md) | [0.0 d](/filings/0001493152-24-011916.md) | [0.0](/filings/0001493152-24-019143.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [2.2](/filings/0001493152-24-045065.md) | [0.8 d](/filings/0001641172-25-001193.md) | [1.9](/filings/0001641172-25-010230.md) | [0.5](/filings/0001493152-25-011912.md) | [(0.7)](/filings/0001493152-25-022223.md) | [0.1 d](/filings/0001493152-26-014042.md) | [(0.4)](/filings/0001493152-26-023510.md) | [0.4](/filings/0001493152-26-038191.md) | [(1.0)](/filings/0001493152-25-022223.md) | [(6.8) d](/filings/0001493152-26-014042.md) | [(2.8)](/filings/0001493152-26-023510.md) | [(2.1)](/filings/0001493152-26-038191.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-038191.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-26-038191.md) |
| Income tax | $m | [0.3](/filings/0001493152-24-045065.md) | [1.1 d](/filings/0001641172-25-001193.md) | [0.5](/filings/0001641172-25-010230.md) | [0.3](/filings/0001493152-25-011912.md) | [0.1](/filings/0001493152-25-022223.md) | [0.0 d](/filings/0001493152-26-014042.md) | [0.0](/filings/0001493152-26-023510.md) | [0.0](/filings/0001493152-26-038191.md) | [0.0 d](/filings/0001493152-25-022223.md) | [(0.1) d](/filings/0001493152-26-014042.md) | [0.0](/filings/0001493152-26-023510.md) | [0.0](/filings/0001493152-26-038191.md) |
| Net income | $m | [2.0](/filings/0001493152-24-045065.md) | [(0.2) d](/filings/0001641172-25-001193.md) | [1.7](/filings/0001641172-25-010230.md) | [0.5](/filings/0001493152-25-011912.md) | [(0.8)](/filings/0001493152-25-022223.md) | [(0.2) d](/filings/0001493152-26-014042.md) | [(0.7)](/filings/0001493152-26-023510.md) | [0.4](/filings/0001493152-26-038191.md) | [(0.9)](/filings/0001493152-25-022223.md) | [(7.8) d](/filings/0001493152-26-014042.md) | [(3.9)](/filings/0001493152-26-023510.md) | [(3.2)](/filings/0001493152-26-038191.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-045065.md) | not reported | [0.00](/filings/0001641172-25-010230.md) | [0.00](/filings/0001493152-25-011912.md) | [0.00](/filings/0001493152-25-022223.md) | not reported | [0.00](/filings/0001493152-26-023510.md) | [0.00](/filings/0001493152-25-011912.md) | [0.00](/filings/0001493152-25-022223.md) | not reported | [0.00](/filings/0001493152-26-023510.md) | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-045065.md) | not reported | [0.00](/filings/0001641172-25-010230.md) | [0.00](/filings/0001493152-25-011912.md) | [0.00](/filings/0001493152-25-022223.md) | not reported | [0.00](/filings/0001493152-26-023510.md) | [0.00](/filings/0001493152-25-011912.md) | [0.00](/filings/0001493152-25-022223.md) | not reported | [0.00](/filings/0001493152-26-023510.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.5](/filings/0001493152-23-040281.md) | [20.9](/filings/0001641172-25-001193.md) | [24.4](/filings/0001493152-24-019143.md) | [23.7](/filings/0001493152-24-031587.md) | [24.5](/filings/0001493152-24-045065.md) | [22.5](/filings/0001493152-26-014042.md) | [17.5](/filings/0001641172-25-010230.md) | [16.2](/filings/0001493152-25-011912.md) | [15.1](/filings/0001493152-25-022223.md) | [10.0](/filings/0001493152-26-038191.md) | [4.5](/filings/0001493152-26-023510.md) | [2.0](/filings/0001493152-26-038191.md) |
| Current assets | $m | [28.0](/filings/0001493152-23-040281.md) | [24.5](/filings/0001641172-25-001193.md) | [27.8](/filings/0001493152-24-019143.md) | [29.5](/filings/0001493152-24-031587.md) | [30.8](/filings/0001493152-24-045065.md) | [27.4](/filings/0001493152-26-014042.md) | [25.2](/filings/0001641172-25-010230.md) | [24.0](/filings/0001493152-25-011912.md) | [20.9](/filings/0001493152-25-022223.md) | [13.0](/filings/0001493152-26-038191.md) | [7.6](/filings/0001493152-26-023510.md) | [4.6](/filings/0001493152-26-038191.md) |
| Total assets | $m | [38.6](/filings/0001493152-23-040281.md) | [33.7](/filings/0001641172-25-001193.md) | [35.8](/filings/0001493152-24-019143.md) | [33.6](/filings/0001493152-24-031587.md) | [32.9](/filings/0001493152-24-045065.md) | [31.6](/filings/0001493152-26-014042.md) | [29.9](/filings/0001641172-25-010230.md) | [29.5](/filings/0001493152-25-011912.md) | [27.5](/filings/0001493152-25-022223.md) | [21.5](/filings/0001493152-26-038191.md) | [17.5](/filings/0001493152-26-023510.md) | [13.5](/filings/0001493152-26-038191.md) |
| Current liabilities | $m | [13.9](/filings/0001493152-23-040281.md) | [12.0](/filings/0001641172-25-001193.md) | [14.8](/filings/0001493152-24-019143.md) | [12.6](/filings/0001493152-24-031587.md) | [13.4](/filings/0001493152-24-045065.md) | [12.3](/filings/0001493152-26-014042.md) | [11.0](/filings/0001641172-25-010230.md) | [9.9](/filings/0001493152-25-011912.md) | [8.5](/filings/0001493152-25-022223.md) | [6.1](/filings/0001493152-26-038191.md) | [5.9](/filings/0001493152-26-023510.md) | [5.5](/filings/0001493152-26-038191.md) |
| Total liabilities | $m | [19.9](/filings/0001493152-23-040281.md) | [14.9](/filings/0001641172-25-001193.md) | [18.7](/filings/0001493152-24-019143.md) | [15.8](/filings/0001493152-24-031587.md) | [15.7](/filings/0001493152-24-045065.md) | [14.4](/filings/0001493152-26-014042.md) | [13.1](/filings/0001641172-25-010230.md) | [12.1](/filings/0001493152-25-011912.md) | [10.8](/filings/0001493152-25-022223.md) | [12.6](/filings/0001493152-26-038191.md) | [12.3](/filings/0001493152-26-023510.md) | [11.9](/filings/0001493152-26-038191.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [18.6](/filings/0001493152-24-045065.md) | [18.8](/filings/0001641172-25-001193.md) | [17.1](/filings/0001493152-24-045065.md) | [17.9](/filings/0001493152-24-045065.md) | [17.2](/filings/0001493152-24-045065.md) | [17.2](/filings/0001493152-26-014042.md) | [16.8](/filings/0001641172-25-010230.md) | [17.4](/filings/0001493152-25-011912.md) | [16.6](/filings/0001493152-25-022223.md) | [8.9](/filings/0001493152-26-038191.md) | [5.2](/filings/0001493152-26-023510.md) | [1.6](/filings/0001493152-26-038191.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,809 d](/filings/0001493152-24-045065.md) | [265 d](/filings/0001641172-25-001193.md) | [4,800](/filings/0001641172-25-010230.md) | [5,476 d](/filings/0001493152-25-011912.md) | [2,747 d](/filings/0001493152-25-022223.md) | [979 d](/filings/0001493152-26-014042.md) | [(3,375)](/filings/0001493152-26-023510.md) | [(341) d](/filings/0001493152-26-038191.md) | [609 d](/filings/0001493152-25-022223.md) | [(593) d](/filings/0001493152-26-014042.md) | [(2,812)](/filings/0001493152-26-023510.md) | [(2,781) d](/filings/0001493152-26-038191.md) |
| Capital expenditure | $k | [121 d](/filings/0001493152-24-045065.md) | [31.8 d](/filings/0001641172-25-001193.md) | [2.9](/filings/0001641172-25-010230.md) | [3.5 d](/filings/0001493152-25-011912.md) | [0.0 d](/filings/0001493152-25-022223.md) | [456 d](/filings/0001493152-26-014042.md) | [324](/filings/0001493152-26-023510.md) | [(182) d](/filings/0001493152-26-038191.md) | [373 d](/filings/0001493152-25-022223.md) | [29.8 d](/filings/0001493152-26-014042.md) | [62.0](/filings/0001493152-26-023510.md) | [70.8 d](/filings/0001493152-26-038191.md) |
| Dividends paid | $k | [159 d](/filings/0001493152-24-045065.md) | [147 d](/filings/0001641172-25-001193.md) | [175](/filings/0001641172-25-010230.md) | [161 d](/filings/0001493152-25-011912.md) | [161 d](/filings/0001493152-25-022223.md) | [162 d](/filings/0001493152-26-014042.md) | [162](/filings/0001493152-26-023510.md) | [175 d](/filings/0001493152-26-038191.md) | [163 d](/filings/0001493152-25-022223.md) | [163 d](/filings/0001493152-26-014042.md) | [163](/filings/0001493152-26-023510.md) | [163 d](/filings/0001493152-26-038191.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,641](/filings/0001493152-23-040281.md) | [3,673](/filings/0001493152-24-019143.md) | [3,673](/filings/0001493152-24-031587.md) | [3,669](/filings/0001493152-24-045065.md) | [3,089](/filings/0001641172-25-010230.md) | [2,897](/filings/0001493152-25-011912.md) | [1,861](/filings/0001493152-25-022223.md) | [1,859](/filings/0001493152-26-023510.md) | [2,895](/filings/0001493152-26-038191.md) | [1,853](/filings/0001493152-25-022223.md) | [1,847](/filings/0001493152-26-023510.md) | [1,847](/filings/0001493152-26-038191.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,844,470,389 at 2026-08-07, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038191.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.